Monopar Therapeutics Inc
F:1IY0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Monopar Therapeutics Inc
F:1IY0
|
US |
|
M
|
Mizuho Financial Group Inc
SWB:MZ8A
|
JP |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
|
Pebble Group PLC
OTC:PEBBF
|
UK |
|
Cheesecake Factory Inc
NASDAQ:CAKE
|
US |
|
H
|
Hermes International SCA
XBER:HMI
|
FR |
|
F
|
Fluor Corp
XBER:FLU
|
US |
|
Cathay Media and Education Group Inc
HKEX:1981
|
CN |
|
Postal Savings Bank of China Co Ltd
SSE:601658
|
CN |
|
D'Ieteren Group NV
LSE:0ON7
|
BE |
|
Endesa SA
MAD:ELE
|
ES |
|
Y
|
Yext Inc
F:0YE
|
US |
|
S
|
Sun Life Financial Inc
XPHS:SLF
|
CA |
|
F
|
Fomento de Construcciones y Contratas SA
SWB:FCC
|
ES |
|
Kering SA
XETRA:PPX
|
FR |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
L
|
Liberty Global PLC
NASDAQ:LBTYK
|
UK |
Bankruptcy Probability
Monopar Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Monopar Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
438.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
48.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Monopar Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Monopar Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
